Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (RIA2020EF-2970)
Received: 15 January 2021
Accepted: 10 July 2021
First Online: 31 July 2021
: ENDOCOVID has received ethics approval from Walter Sisulu University, South Africa (EC_202011_006 and 053/2020), as well as University of Illorin Teaching Hospital, Nigeria (NHREC/02/05/2010) and Lagos State University Teaching Hospital, Nigeria (NHREC04/04/2008). Verbal and written informed consent will be obtained from each participant prior to being included into the study. The study was registered under clinicaltrials.gov: NCT04709302, 13 January 2021, ExternalRef removed.
: Not applicable.
: All authors declare no competing financial interests.